These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33830086)

  • 1. Method for selective ablation of undifferentiated human pluripotent stem cell populations for cell-based therapies.
    Chour T; Tian L; Lau E; Thomas D; Itzhaki I; Malak O; Zhang JZ; Qin X; Wardak M; Liu Y; Chandy M; Black KE; Lam MP; Neofytou E; Wu JC
    JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33830086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STB-HO, a novel mica fine particle, inhibits the teratoma-forming ability of human embryonic stem cells after in vivo transplantation.
    Choi SW; Shin TH; Uddin MH; Shin JH; Kang TW; Lee BC; Kim HS; Seo Y; Shams S; Jung YK; Kang KS
    Oncotarget; 2016 Jan; 7(3):2684-95. PubMed ID: 26646796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new class of pluripotent stem cell cytotoxic small molecules.
    Richards M; Phoon CW; Goh GT; Seng EK; Guo XM; Tan CM; Chan WK; Lee JM
    PLoS One; 2014; 9(3):e85039. PubMed ID: 24647085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and functional resemblance of differentiated cells derived from isogenic human iPSCs and SCNT-derived ESCs.
    Zhao MT; Chen H; Liu Q; Shao NY; Sayed N; Wo HT; Zhang JZ; Ong SG; Liu C; Kim Y; Yang H; Chour T; Ma H; Gutierrez NM; Karakikes I; Mitalipov S; Snyder MP; Wu JC
    Proc Natl Acad Sci U S A; 2017 Dec; 114(52):E11111-E11120. PubMed ID: 29203658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct Responses of Stem Cells to Telomere Uncapping-A Potential Strategy to Improve the Safety of Cell Therapy.
    Liu CC; Ma DL; Yan TD; Fan X; Poon Z; Poon LF; Goh SA; Rozen SG; Hwang WY; Tergaonkar V; Tan P; Ghosh S; Virshup DM; Goh EL; Li S
    Stem Cells; 2016 Oct; 34(10):2471-2484. PubMed ID: 27299710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repair of Ischemic Injury by Pluripotent Stem Cell Based Cell Therapy without Teratoma through Selective Photosensitivity.
    Cho SJ; Kim SY; Jeong HC; Cheong H; Kim D; Park SJ; Choi JJ; Kim H; Chung HM; Moon SH; Cha HJ
    Stem Cell Reports; 2015 Dec; 5(6):1067-1080. PubMed ID: 26584542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes.
    Hemmi N; Tohyama S; Nakajima K; Kanazawa H; Suzuki T; Hattori F; Seki T; Kishino Y; Hirano A; Okada M; Tabei R; Ohno R; Fujita C; Haruna T; Yuasa S; Sano M; Fujita J; Fukuda K
    Stem Cells Transl Med; 2014 Dec; 3(12):1473-83. PubMed ID: 25355733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic population derived from human pluripotent stem cells is effectively increased by selective removal of undifferentiated stem cells using YM155.
    Kang SJ; Park YI; Hwang SR; Yi H; Tham N; Ku HO; Song JY; Kang HG
    Stem Cell Res Ther; 2017 Apr; 8(1):78. PubMed ID: 28412976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling cadmium-induced cardiotoxicity using human pluripotent stem cell-derived cardiomyocytes.
    Shen J; Wang X; Zhou D; Li T; Tang L; Gong T; Su J; Liang P
    J Cell Mol Med; 2018 Sep; 22(9):4221-4235. PubMed ID: 29993192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel biomarkers for doxorubicin-induced toxicity in human cardiomyocytes derived from pluripotent stem cells.
    Holmgren G; Synnergren J; Bogestål Y; Améen C; Åkesson K; Holmgren S; Lindahl A; Sartipy P
    Toxicology; 2015 Feb; 328():102-11. PubMed ID: 25529476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human somatostatin receptor type 2 as an imaging and suicide reporter gene for pluripotent stem cell-derived therapy of myocardial infarction.
    Neyrinck K; Breuls N; Holvoet B; Oosterlinck W; Wolfs E; Vanbilloen H; Gheysens O; Duelen R; Gsell W; Lambrichts I; Himmelreich U; Verfaillie CM; Sampaolesi M; Deroose CM
    Theranostics; 2018; 8(10):2799-2813. PubMed ID: 29774076
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclooxygenases Inhibitors Efficiently Induce Cardiomyogenesis in Human Pluripotent Stem Cells.
    Nemade H; Acharya A; Chaudhari U; Nembo E; Nguemo F; Riet N; Abken H; Hescheler J; Papadopoulos S; Sachinidis A
    Cells; 2020 Feb; 9(3):. PubMed ID: 32120775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Human Pluripotent Stem Cell Derived-Cardiomyocytes to Study Drug-Induced Cardiotoxicity.
    Maillet A; Tan KP; Brunham LR
    Curr Protoc Toxicol; 2017 Aug; 73():22.5.1-22.5.22. PubMed ID: 28777443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiotoxicity evaluation using human embryonic stem cells and induced pluripotent stem cell-derived cardiomyocytes.
    Zhao Q; Wang X; Wang S; Song Z; Wang J; Ma J
    Stem Cell Res Ther; 2017 Mar; 8(1):54. PubMed ID: 28279214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prunellae Spica Extract Suppresses Teratoma Formation of Pluripotent Stem Cells through p53-Mediated Apoptosis.
    Kim A; Lee SY; Seo CS; Chung SK
    Nutrients; 2020 Mar; 12(3):. PubMed ID: 32182802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JS-K, a GST-activated nitric oxide donor prodrug, enhances chemo-sensitivity in renal carcinoma cells and prevents cardiac myocytes toxicity induced by Doxorubicin.
    Qiu M; Ke L; Zhang S; Zeng X; Fang Z; Liu J
    Cancer Chemother Pharmacol; 2017 Aug; 80(2):275-286. PubMed ID: 28608259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptotic susceptibility to DNA damage of pluripotent stem cells facilitates pharmacologic purging of teratoma risk.
    Smith AJ; Nelson NG; Oommen S; Hartjes KA; Folmes CD; Terzic A; Nelson TJ
    Stem Cells Transl Med; 2012 Oct; 1(10):709-18. PubMed ID: 23197662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mifepristone-inducible caspase-1 expression in mouse embryonic stem cells eliminates tumor formation but spares differentiated cells in vitro and in vivo.
    Wang Y; Yang D; Song L; Li T; Yang J; Zhang X; Le W
    Stem Cells; 2012 Feb; 30(2):169-79. PubMed ID: 22131096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic and chemical targeting of the tight-junction protein Claudin-6 eliminates tumorigenic human pluripotent stem cells.
    Ben-David U; Nudel N; Benvenisty N
    Nat Commun; 2013; 4():1992. PubMed ID: 23778593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Proteomics Study Reveals Changes in the Molecular Landscape of Human Embryonic Stem Cells with Impaired Stem Cell Differentiation upon Exposure to Titanium Dioxide Nanoparticles.
    Pan L; Lee YM; Lim TK; Lin Q; Xu X
    Small; 2018 Jun; 14(23):e1800190. PubMed ID: 29741810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.